Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

DOPAMINE IN MAN: CARDIORENAL HEMODYNAMICS IN NORMOTENSIVE PATIENTS WITH HEART DISEASE

ROBERT ROSENBLUM, ABDUR RAZZAK TAI and DIANA LAWSON
Journal of Pharmacology and Experimental Therapeutics November 1972, 183 (2) 256-263;
ROBERT ROSENBLUM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ABDUR RAZZAK TAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DIANA LAWSON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Simultaneous measurements of cardiac and renal hemodynamics were obtained in 20 patients who were undergoing diagnostic cardiac catheterization. After control observations were obtained, dopamine was infused for 11 to 89 minutes at 2.1 to 5.8 µg/kg/min. In 16 of 19 patients cardiac index increased (+26%) with no significant change in heart rate or oxygen consumption. Pulmonary resistance, when elevated, decreased, and peripheral resistance decreased whether initially elevated or normal. Glomerular filtration rate increased in 15 of 20 subjects (+38%), and renal plasma flow and sodium excretion increased in 19 of 20 patients by +79% and +486%, respectively. Dopamine is the only known catecholamine which causes an increase in cardiac output associated with a marked increase in sodium excretion, renal blood flow and glomerular filtration rate

Footnotes

    • Received October 7, 1971.
    • Accepted July 14, 1972.
  • © 1972 by The Williams & Wilkins Co.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 183, Issue 2
1 Nov 1972
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
DOPAMINE IN MAN: CARDIORENAL HEMODYNAMICS IN NORMOTENSIVE PATIENTS WITH HEART DISEASE
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

DOPAMINE IN MAN: CARDIORENAL HEMODYNAMICS IN NORMOTENSIVE PATIENTS WITH HEART DISEASE

ROBERT ROSENBLUM, ABDUR RAZZAK TAI and DIANA LAWSON
Journal of Pharmacology and Experimental Therapeutics November 1, 1972, 183 (2) 256-263;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

DOPAMINE IN MAN: CARDIORENAL HEMODYNAMICS IN NORMOTENSIVE PATIENTS WITH HEART DISEASE

ROBERT ROSENBLUM, ABDUR RAZZAK TAI and DIANA LAWSON
Journal of Pharmacology and Experimental Therapeutics November 1, 1972, 183 (2) 256-263;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Toxicity, Biological Activity, and Pharmacokinetics of TXU (Anti-CD7)-Pokeweed Antiviral Protein in Chimpanzees and Adult Patients Infected with Human Immunodeficiency Virus
  • Evidence That Melanocortin 4 Receptor Mediates Hemorrhagic Shock Reversal Caused by Melanocortin Peptides
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics